Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$446,965
+$11,322 QoQ
Shares Held
2,852
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#938
of 1,603 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026one8zero8, LLC holds $21,932,963 across 7 Drug Manufacturers - General names. NVS ranks #6 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
58,659 | $14,897,626 | |
| 2 | ABBV |
AbbVie Inc.
|
9,418 | $2,369,945 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
33,580 | $1,934,879 | |
| 4 | LLY |
ELI LILLY & Co
|
860 | $1,031,509 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,460 | $830,110 | |
| 6 | NVS |
Novartis AG
This page
|
2,852 | $446,965 | |
| 7 | PFE |
Pfizer Inc
|
17,522 | $421,929 |
All Filings in NVS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $446,965 | 2,852 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $435,643 | 2,852 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $393,205 | 2,852 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $365,740 | 2,852 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $273,966 | 2,264 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $319,278 | 2,864 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $278,695 | 2,864 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||